Chugai Pharma Europe Ltd is a privately held limited company established in 1997 and currently active. Based in London, UK, the company operates as a subsidiary of Chugai Pharmaceutical Co., Ltd., a Japanese biopharma organization focused on human health. Chugai Pharma Europe’s primary service offering centers around providing pharmaceutical support and strategic guidance to clients within the European market. The company specializes in facilitating the development, regulatory compliance, and commercialization of pharmaceutical products. As a Ltd company, Chugai Pharma Europe’s operations are governed by the SIC codes - 70100, indicating a focus on head office activities. The company’s international presence is significant, demonstrating a commitment to global collaboration. Currently, Chugai Pharma Europe is classified as a Worker (A rating) and operates under Visa: Global Business Mobility, signifying a senior or specialist worker role. The company’s key focus is supporting clients through various stages of the pharmaceutical lifecycle, encompassing market entry, clinical trial management, and post-market surveillance. It’s a dedicated provider of pharmaceutical expertise and support within the European region.

Chugai Pharma Europe Ltd is a privately held limited company established in 1997 and currently active. Based in London, UK, the company operates as a subsidiary of Chugai Pharmaceutical Co., Ltd., a Japanese biopharma organization focused on human health. Chugai Pharma Europe’s primary service offering centers around providing pharmaceutical support and strategic guidance to clients within the European market. The company specializes in facilitating the development, regulatory compliance, and commercialization of pharmaceutical products. As a Ltd company, Chugai Pharma Europe’s operations are governed by the SIC codes - 70100, indicating a focus on head office activities. The company’s international presence is significant, demonstrating a commitment to global collaboration. Currently, Chugai Pharma Europe is classified as a Worker (A rating) and operates under Visa: Global Business Mobility, signifying a senior or specialist worker role. The company’s key focus is supporting clients through various stages of the pharmaceutical lifecycle, encompassing market entry, clinical trial management, and post-market surveillance. It’s a dedicated provider of pharmaceutical expertise and support within the European region.